Dear

We are delighted to announce that the University of Oxford Isis Fund I, an EIS Fund established by Parkwalk and Isis Innovation, the University’s research commercialisation arm, has closed, oversubscribed.

The Fund allows private investors to make tax efficient investments in a range of new Oxford spin-out companies and will invest across all areas of technology and intellectual property from Oxford. 

Isis Innovation managing director Tom Hockaday said: “We would like to thank the investors in the Fund for their support. This is a real vote of confidence in future Oxford technologies, and we look forward to working with Parkwalk as the Fund makes its first investments.”

A second fund is planned once the current fund is fully invested - please contact us on 020 7759 2285 or by clicking here if you would like to be notified when the University of Oxford Isis Fund II opens to new investors.

Meanwhile, Parkwalk Fund V will remain open to new investors until it makes its first investment - please contact us on 020 7759 2285 or by clicking here if you would like more details.

Parkwalk invests in high-growth British technology companies across all stages of their development, from formation through to AIM-listed companies. 

Parkwalk’s current portfolio consists of 27 companies, which have raised in excess of £250m of funding between them since 2010 and over 600 patents protect their technology and processes.

Overall, Funds I-IV’s portfolio comprises of 9% Series ‘A’, 33% Series ‘B’, 25% Pre-IPO and 33% AIM listed.

As of Q1 2014 every £1.00 invested across Parkwalk Funds I-IV was valued at £1.52 (£2.17 net of tax reliefs) and the valuations for Parkwalk Funds are published monthly here.

Valuations as of 25th March 2014. Net NAV includes income tax relief and fees on investment

Past performance is no guide to future performance. The price of a fund can fall as well as rise. Investors may receive back less than originally invested.